1
|
Ramalingam SS, Owonikoko TK and Khuri FR:
Lung cancer: New biological insights and recent therapeutic
advances. CA Cancer J Clin. 61:91–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Reck M, Heigener DF, Mok T, Soria JC and
Rabe KF: Management of non-small-cell lung cancer: Recent
developments. Lancet. 382:709–719. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kim WK, Pyee Y, Chung HJ, Park HJ, Hong
JY, Son KH and Lee SK: Antitumor activity of spicatoside a by
modulation of autophagy and apoptosis in human colorectal cancer
cells. J Nat Prod. 79:1097–1104. 2016. View Article : Google Scholar : PubMed/NCBI
|
4
|
White E: Deconvoluting the
context-dependent role for autophagy in cancer. Nat Rev Cancer.
12:401–410. 2012. View
Article : Google Scholar : PubMed/NCBI
|
5
|
Ge J, Liu Y, Li Q, Guo X, Gu L, Ma ZG and
Zhu YP: Resveratrol induces apoptosis and autophagy in T-cell acute
lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating
p38-MAPK. Biomed Environ Sci. 26:902–911. 2013.PubMed/NCBI
|
6
|
Kumar D, Das B, Sen R, Kundu P, Manna A,
Sarkar A, Chowdhury C, Chatterjee M and Das P: Andrographolide
analogue induces apoptosis and autophagy mediated cell death in
U937 cells by inhibition of PI3K/Akt/mTOR pathway. PLoS One.
10:e01396572015. View Article : Google Scholar : PubMed/NCBI
|
7
|
Saiki S, Sasazawa Y, Imamichi Y, Kawajiri
S, Fujimaki T, Tanida I, Kobayashi H, Sato F, Sato S, Ishikawa K,
et al: Caffeine induces apoptosis by enhancement of autophagy via
PI3K/Akt/mTOR/p70S6K inhibition. Autophagy. 7:176–187. 2011.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Zhou ZW, Li XX, He ZX, Pan ST, Yang Y,
Zhang X, Chow K, Yang T, Qiu JX, Zhou Q, et al: Induction of
apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated
pathways by plumbagin in human prostate cancer cells. Drug Des
Devel Ther. 9:1511–1554. 2015. View Article : Google Scholar : PubMed/NCBI
|
9
|
Gills JJ, Lopiccolo J and Dennis PA:
Nelfinavir, a new anti-cancer drug with pleiotropic effects and
many paths to autophagy. Autophagy. 4:107–109. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Gupta SC, Patchva S and Aggarwal BB:
Therapeutic roles of curcumin: Lessons learned from clinical
trials. AAPS J. 15:195–218. 2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhou GZ, Cao FK, Chang JM, Sun GC and Chen
XB: Mechanism of curcumin analog MHMD-induced cell death in A549
lung cancer cells. Eur Rev Med Pharmacol Sci. 18:3134–3138.
2014.PubMed/NCBI
|
12
|
Chang CC, Fu CF, Yang WT, Chen TY and Hsu
YC: The cellular uptake and cytotoxic effect of curcuminoids on
breast cancer cells. Taiwan J Obstet Gynecol. 51:368–374. 2012.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Liu D, You M, Xu Y, Li F, Zhang D, Li X
and Hou Y: Inhibition of curcumin on myeloid-derived suppressor
cells is requisite for controlling lung cancer. Int
Immunopharmacol. 39:265–272. 2016. View Article : Google Scholar : PubMed/NCBI
|
14
|
Watson JL, Greenshields A, Hill R, Hilchie
A, Lee PW, Giacomantonio CA and Hoskin DW: Curcumin-induced
apoptosis in ovarian carcinoma cells is p53-independent and
involves p38 mitogen-activated protein kinase activation and
downregulation of Bcl-2 and survivin expression and Akt signaling.
Mol Carcinog. 49:13–24. 2010.PubMed/NCBI
|
15
|
Zhang J, Zhang T, Ti X, Shi J, Wu C, Ren X
and Yin H: Curcumin promotes apoptosis in A549/DDP
multidrug-resistant human lung adenocarcinoma cells through an
miRNA signaling pathway. Biochem Biophys Res Commun. 399:1–6. 2010.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Thongrakard V, Titone R, Follo C, Morani
F, Suksamrarn A, Tencomnao T and Isidoro C: Turmeric toxicity in
A431 epidermoid cancer cells associates with autophagy degradation
of anti-apoptotic and anti-autophagic p53 mutant. Phytother Res.
28:1761–1769. 2014. View
Article : Google Scholar : PubMed/NCBI
|
17
|
Liu F, Gao S, Yang Y, Zhao X, Fan Y, Ma W,
Yang D, Yang A and Yu Y: Curcumin induced autophagy anticancer
effects on human lung adenocarcinoma cell line A549. Oncol Lett.
14:2775–2782. 2017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Jiao D, Wang J, Lu W, Tang X, Chen J, Mou
H and Chen QY: Curcumin inhibited HGF-induced EMT and angiogenesis
through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways
in lung cancer. Mol Ther Oncolytics. 3:160182016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wang Y, Zhou T, Sun H and Huang B: Study
on the relationship between autophagy and apoptosis in a549 cells
induced by curcumin analogue EF24. Chin J Cell Biol. 34:590–596.
2012.
|
20
|
Chang L, Graham PH, Hao J, Ni J, Bucci J,
Cozzi PJ, Kearsley JH and Li Y: Acquisition of
epithelial-mesenchymal transition and cancer stem cell phenotypes
is associated with activation of the PI3K/Akt/mTOR pathway in
prostate cancer radioresistance. Cell Death Dis. 4:e8752013.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Graupera M and Potente M: Regulation of
angiogenesis by PI3K signaling networks. Exp Cell Res.
319:1348–1355. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Huo R, Wang L, Liu P, Zhao Y, Zhang C, Bai
B, Liu X, Shi C, Wei S and Zhang H: Cabazitaxel-induced autophagy
via the PI3K/Akt/mTOR pathway contributes to A549 cell death. Mol
Med Rep. 14:3013–3020. 2016. View Article : Google Scholar : PubMed/NCBI
|
23
|
Jiang LB, Cao L, Yin XF, Yasen M, Yishake
M, Dong J and Li XL: Activation of autophagy via Ca(2+)-dependent
AMPK/mTOR pathway in rat notochordal cells is a cellular adaptation
under hyperosmotic stress. Cell Cycle. 14:867–879. 2015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A,
Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX and Ye WC:
Arenobufagin, a natural bufadienolide from toad venom, induces
apoptosis and autophagy in human hepatocellular carcinoma cells
through inhibition of PI3K/Akt/mTOR pathway. Carcinogenesis.
34:1331–1342. 2013. View Article : Google Scholar : PubMed/NCBI
|
25
|
Gali-Muhtasib H, Hmadi R, Kareh M, Tohme R
and Darwiche N: Cell death mechanisms of plant-derived anticancer
drugs: Beyond apoptosis. Apoptosis. 20:1531–1562. 2015. View Article : Google Scholar : PubMed/NCBI
|
26
|
Tsai JP, Lee CH, Ying TH, Lin CL, Lin CL,
Hsueh JT and Hsieh YH: Licochalcone A induces autophagy through
PI3K/Akt/mTOR inactivation and autophagy suppression enhances
Licochalcone A-induced apoptosis of human cervical cancer cells.
Oncotarget. 6:28851–28866. 2015. View Article : Google Scholar : PubMed/NCBI
|
27
|
Kumar S, Guru SK, Pathania AS, Manda S,
Kumar A, Bharate SB, Vishwakarma RA, Malik F and Bhushan S:
Fascaplysin induces caspase mediated crosstalk between apoptosis
and autophagy through the inhibition of PI3K/AKT/mTOR signaling
cascade in human leukemia HL-60 cells. J Cell Biochem. 116:985–997.
2015. View Article : Google Scholar : PubMed/NCBI
|
28
|
Turcotte S and Giaccia AJ: Targeting
cancer cells through autophagy for anticancer therapy. Current Opin
Cell Biol. 22:246–251. 2010. View Article : Google Scholar
|
29
|
Wang K, Liu R, Li J, Mao J, Lei Y, Wu J,
Zeng J, Zhang T, Wu H, Chen L, et al: Quercetin induces protective
autophagy in gastric cancer cells: Involvement of Akt-mTOR- and
hypoxia-induced factor 1alpha-mediated signaling. Autophagy.
7:966–978. 2011. View Article : Google Scholar : PubMed/NCBI
|
30
|
Liu Z, Wang F, Zhou ZW, Xia HC, Wang XY,
Yang YX, He ZX, Sun T and Zhou SF: Alisertib induces G2/M arrest,
apoptosis, and autophagy via PI3K/Akt/mTOR- and p38 MAPK-mediated
pathways in human glioblastoma cells. Am J Transl Res. 9:845–873.
2017.PubMed/NCBI
|
31
|
Wang F, Mao Y, You Q, Hua D and Cai D:
Piperlongumine induces apoptosis and autophagy in human lung cancer
cells through inhibition of PI3K/Akt/mTOR pathway. Int J
Immunopathol Pharmacol. 28:362–373. 2015. View Article : Google Scholar : PubMed/NCBI
|
32
|
Tirado OM, Mateo-Lozano S and Notario V:
Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the
Bax: Bcl-xL ratio through concurrent mechanisms dependent and
independent of its mTOR inhibitory activity. Oncogene.
24:3348–3357. 2005. View Article : Google Scholar : PubMed/NCBI
|
33
|
Bilir A, Erguven M, Oktem G, Ozdemir A,
Uslu A, Aktas E and Bonavida B: Potentiation of cytotoxicity by
combination of imatinib and chlorimipramine in glioma. Int J Oncol.
32:829–839. 2008.PubMed/NCBI
|